서브메뉴
검색
Overcoming Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma: Micro- and Nanotechnology-Based Drug Delivery as Novel Therapeutic Strategies.
Overcoming Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma: Micro- and Nanotechnology-Based Drug Delivery as Novel Therapeutic Strategies.
- 자료유형
- 학위논문
- Control Number
- 0017164724
- International Standard Book Number
- 9798346758570
- Dewey Decimal Classification Number
- 610
- Main Entry-Personal Name
- Li, Xiyao.
- Publication, Distribution, etc. (Imprint
- [S.l.] : University of California, Los Angeles., 2024
- Publication, Distribution, etc. (Imprint
- Ann Arbor : ProQuest Dissertations & Theses, 2024
- Physical Description
- 119 p.
- General Note
- Source: Dissertations Abstracts International, Volume: 86-06, Section: B.
- General Note
- Advisor: Li, Song.
- Dissertation Note
- Thesis (Ph.D.)--University of California, Los Angeles, 2024.
- Summary, Etc.
- 요약Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide. For most HNSCC patients with locally advanced disease, platinum-based drugs, especially cisplatin, remain the gold standard to reduce the risk of recurrence and improve survival rate. Drug resistance, however, is the main issue obstructing the optimum cisplatin therapeutic efficiency. In this dissertation research, two auxiliary systems were designed to overcome the cisplatin resistance in HNSCC. The first system loaded a small molecule drug with high therapeutic efficacy into polymer microparticles. Upon the intratumoral injection through microneedle, a local and sustained release was achieved, leading to suppressed proliferation, inhibited migration, and promoted apoptosis of cancer cells. The second system involves the design of a novel enzyme delivery system to target tumor microenvironment, which not only reduces cancer cell viability, migration, and invasion, but also activates immune response. The strategies described in this dissertation research can be extended to other small molecule drugs or therapeutic proteins for cancer therapies beyond cisplatin-resistant HNSCC, providing a platform for more effective cancer therapy.
- Subject Added Entry-Topical Term
- Bioengineering.
- Subject Added Entry-Topical Term
- Cellular biology.
- Subject Added Entry-Topical Term
- Oncology.
- Index Term-Uncontrolled
- Cancer therapy
- Index Term-Uncontrolled
- Head and neck squamous cell carcinoma
- Index Term-Uncontrolled
- Polymer microparticles
- Added Entry-Corporate Name
- University of California, Los Angeles Bioengineering 0288
- Host Item Entry
- Dissertations Abstracts International. 86-06B.
- Electronic Location and Access
- 로그인을 한후 보실 수 있는 자료입니다.
- Control Number
- joongbu:656412
detalle info
- Reserva
- 캠퍼스간 도서대출
- 서가에 없는 책 신고
- Mi carpeta